Pulsed-dye laser treatment for inflammatory acne vulgaris: Randomised controlled trial

Lancet

Volumn 362, Issue 9393, 2003, Pages 1347-1352

  Seaton, E D ^a   Charakida, A ^a   Mouser, P E ^a   Grace, I ^b   Clement, R M ^c   Chu, A C ^a  

^a HAMMERSMITH HOSPITAL   (United Kingdom)

^b IMPERIAL COLLEGE LONDON   (United Kingdom)

^c SWANSEA UNIVERSITY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ACNE VULGARIS; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRY SKIN; EYE DISEASE; FEMALE; HUMAN; LIP DISEASE; LOW LEVEL LASER THERAPY; MALE; PAIN; PRIORITY JOURNAL; PRURITUS; PULSED DYE LASER; PURPURA; RANDOMIZED CONTROLLED TRIAL; STATISTICAL SIGNIFICANCE; TREATMENT OUTCOME;

EID: 0242317391     PISSN: 01406736     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0140-6736(03)14629-6     Document Type: Article

References (29)

1. Jowett S., Ryan T. Skin disease and handicap: an analysis of the impact of skin conditions. Soc Sci Med. 20:1985;425-429.
2. Gupta M.A., Gupta A.K. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol. 139:1998;846-850.
3. Cotterill J.A., Cunliffe W.J. Suicide in dermatological patients. Br J Dermatol. 137:1997;246-250.
4. Cunliffe W.J. Unemployment and acne. Br J Dermatol. 115:1986;386.
5. Norris J.F., Cunliffe W.J. A histological and immunocytochemical study of early acne lesions. Br J Dermatol. 118:1988;651-659.
6. Mouser PE, Baker BS, Seaton ED, Chu AC. Propionibacterium acnes reactive Th-1 cells in the skin of patients with acne vulgaris. J Invest Dermatol (in press).
7. Leyden J.L., McGinley K.J., Mills O.H., Kligman A.M. Propionibacterium levels in patients with and without acne vulgaris. J Invest Dermatol. 65:1975;382-384.
8. Eady E.A., Jones C.E., Tipper J.L., Cove J.H., Cunliffe W.J., Layton A.M. Antibiotic resistant propionibacteria in acne: need for policies to modify antibiotic usage. BMJ. 306:1993;555-556.
9. Kjeldstad B., Johnsson A. An action spectrum for blue and near ultraviolet inactivation of Propionibacterium acnes; with emphasis on a possible porphyrin photosenstisation. Photochem Photobiol. 43:1986;67-70.
10. Melo T.B. Uptake of protoporphyrin and violet light photodestruction of Propionibacterium acnes. Z Naturforsch [C]. 42:1987;123-128.
11. Papageorgiou P., Katsambas A., Chu A.C. Phototherapy with blue (415nm) and red (660nm) light in the treatment of acne vulgaris. Br J Dermatol. 142:2000;973-978.
12. Stillman S., Geen S., Harth Y., Shalita A.R. High intensity narrow band blue light is effective in the treatment of acne vulgaris: an in vitro and in vivo study. J Eur Acad Dermatol Venereol. 14:(suppl 1):2000;47.
13. Tan O.T., Sherwood K., Gilchrest B.A. Treatment of children with port wine stains using the flashlamp-pumped tunable pulsed dye laser. N Engl J Med. 320:1989;416-421.
14. Bjerring P., Clement M., Heickendorff L., Lybecker H., Kiernan M. Dermal collagen production following irradiation by dye laser and broad-band light source. J Cosmet Laser Ther. 3:2002;39-43.
15. Bjerring P., Clement M., Heickendorff L., Egekvist H., Kiernan M. Selective non-ablative wrinkle reduction by laser. J Cut Las Ther. 2:2000;9-15.
16. Patel N., Clement M. Selective nonablative treatment of acne scarring with 585nm flashpump pulsed dye laser. Dermatol Surg. 28:2002;942-945.
17. O'Brien S.C., Lewis J.B., Cunliffe W.J. The Leeds revised acne grading system. J Dermatol Treatment. 9:1998;215-220.
18. Lehmann H.P., Robinson K.A., Andrews J.S., Holloway V., Goodman S.N. Acne therapy: a methodologic review. J Am Acad Dermatol. 47:2002;231-240.
19. Lucky A.W., Barber B.L., Girman C.J., Williams J., Ratterman J., Waldstreicher J. A multirater validation study to assess the reliability of acne lesion counting. J Am Acad Dermatol. 35:1996;559-565.
20. Altman D.G. Practical statistics for medical research. 1991;Chapman and Hall, London.
21. Greenwood R., Burke B., Cunliffe W.J. Evaluation of a therapeutic strategy for the treatment of acne vulgaris with conventional therapy. Br J Dermatol. 114:1986;353-358.
22. Olsen T.E. Therapy of acne. Med Clin North Am. 66:1982;851-877.
23. Crawford W.W., Crawford I.P., Staughton R.B., Cornell R.C. Laboratory induction and clinical occurrence of combined clindamycin and erythromycin resistance in Corynebacterium acnes. J Invest Dermatol. 72:1979;187-190.
24. Coates P., Vyakrnam S., Eady E.A., Jones C.E., Cove J.H., Cunliffe W.J. Prevalence of antibiotic-resistant propionibacteria on the skin of acne patients: 10-year surveillance data and snapshot distribution study. Br J Dermatol. 146:2002;840-848.
25. Center for Disease Control and Prevention, Food and Drug Administration, and National Institutes of Health. A public health action plan to combat antimicrobial resistance: part 1 - domestic issues. http://www.cdc.gov/ drugresistance/actionplan/aractionplan.pdf (accessed Aug 12, 2003).
26. Antimicrobial resistance strategy and action plan. 2000;23 Department of Health, London.
27. Ortonne J.P. Oral isotretinoin treatment policy: do we all agree? Dermatol. 195:(suppl 1):1997;34-37.
28. US Food and Drug Administration, Center for Drug Evaluation and Research. Accutane label (revised) 2002 drug information. http://www.fda.gov/cder/foi/ label/2002/18662s051lbl.pdf (accessed Aug 12, 2003).
29. Mitchell A.A., van Bennekom C.M., Louik C. A pregnancy prevention program in women of childbearing age receiving isotretinoin. N Engl J Med. 333:1995;101-106.